While it is established that Wnt/β-catenin activation is associated with poor prognosis in ACC, we observed lacking association between CTNNB1 nucleocytoplasmic staining and clinical parameters in our cohort. The gene discussed is CTNNB1; the disease is adrenal cortex carcinoma.